Dynavax enters sublease with Metagenomi for 75,662 sq ft after Zymergen bankruptcy

DYNAVAX TECHNOLOGIES CORP

Zymergen sublease terminated via Termination Agreement approved by bankruptcy court on Feb 22, 2024.
New sublease with Metagenomi for entire premises at 5959 Horton St, Emeryville, initial monthly rent $493,354.
Rent abated 50% through June 30, 2024; term runs through March 31, 2031, concurrent with master lease.
Master Landlord consented on March 7, 2024; Sublease to be filed with Q1 2024 10-Q.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

DYNAVAX TECHNOLOGIES CORP entered into Office/Laboratory Lease with Emery Station West, LLC valued at lease of approximately 75,662 sq ft at 5959 Horton Street, Emeryville, California (effective 2018-09-17).

Action: entry
Agreement: lease
Counterparty: Emery Station West, LLC
Value: lease of approximately 75,662 sq ft at 5959 Horton Street, Emeryville, California
Effective: 2018-09-17

Exact text from the filing

on September 17, 2018, Dynavax Technologies Corporation (the “Company”) entered into an Office/Laboratory Lease (“Master Lease”) with Emery Station West, LLC (“Master Landlord”) to lease approximately 75,662 square feet of office/laboratory space located at 5959 Horton Street, Emeryville, California (“Premises”).

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.98

DYNAVAX TECHNOLOGIES CORP terminated Termination and Release Agreement with Zymergen Inc. and Metagenomi, Inc. valued at termination of Zymergen Sublease effective upon satisfaction of conditions precedent (effective 2024-02-22).

Action: termination
Agreement: lease
Counterparty: Zymergen Inc. and Metagenomi, Inc.
Value: termination of Zymergen Sublease effective upon satisfaction of conditions precedent
Effective: 2024-02-22

Exact text from the filing

the Company, Zymergen and Metagenomi, Inc. (“Metagenomi”) entered into that certain Termination and Release Agreement dated February 22, 2024 (the “Termination Agreement”), pursuant to which the Zymergen Sublease will terminate effective as of the date the conditions precedent set forth in the Termination Agreement have been satisfied.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.98

DYNAVAX TECHNOLOGIES CORP entered into Sublease with Metagenomi, Inc. valued at initial monthly base rate $493,354.08 with 50% abatement through June 30, 2024, term through March 3 (effective 2024-03-07).

Action: entry
Agreement: lease
Counterparty: Metagenomi, Inc.
Value: initial monthly base rate $493,354.08 with 50% abatement through June 30, 2024, term through March 3
Effective: 2024-03-07

Exact text from the filing

On March 7, 2024, the Company, as sublandlord, entered into a sublease (the “Sublease”) with Metagenomi, as subtenant, for the Premises.

View on SEC.gov

565 material agreements filed in the last 30 days. Browse all material agreements →

Source: SEC EDGAR

accession 0000950170-24-029912

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.